Aberrant CpG Island Hypermethylation of RASSF1A in Gastric Cardia Adenocarcinoma

REFERENCES

• Yang C. S. Vitamin nutrition and gastroesophageal cancer. J Nutr 2000; 130(2S Suppl.)338S–339S
   PubMedGoogle Scholar
• Yokokawa Y., Ohta S., Hou J., Zhang X. L., Li S. S., Ping Y. M., et al. Ecological study on the risks of esophageal cancer in Ci-Xian, China: the importance of nutritional status and the use of well water. Int J Cancer 1999; 83(5)620–624
   PubMed Web of Science ®Google Scholar
• Launoy G., Milan C. H., Faivre J., Pienkowski P., Milan C. I., Gignoux M. Alcohol, tobacco and oesophageal cancer: effects of the duration of consumption, mean intake and current and former consumption. Br J Cancer 1997; 75(9)1389–1396
   PubMed Web of Science ®Google Scholar
• Jones P. A., Buckley J. D. The role of DNA methylation in cancer. Adv Cancer Res 1990; 54: 1–23
   PubMedGoogle Scholar
• Dammann R., Li C., Yoon J. H., Chin P. L., Bates S., Pfeifer G. P. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 2000; 25(3)315–319
   PubMed Web of Science ®Google Scholar
• Ponting C. P., Benjamin D. R. A novel family of Ras-binding domains. Trends Biochem Sci 1996; 21(11)422–425
   PubMed Web of Science ®Google Scholar
• Vavvas D., Li X., Avruch J., Zhang X. F. Identification of Nore1 as a potential Ras effector. J Biol Chem 1998; 273(10)5439–5442
   PubMed Web of Science ®Google Scholar
• Agathanggelou A., Honorio S., Macartney D. P., Martinez A., Dallol A., Rader J., et al. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours. Oncogene 2001; 20(12)1509–1518
   PubMed Web of Science ®Google Scholar
• Burbee D. G., Forgacs E., Zochbauer-Muller S., Shivakumar L., Fong K., Gao B., et al. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J Natl Cancer Inst 2001; 93(9)691–699
   PubMed Web of Science ®Google Scholar
• Dammann R., Yang G., Pfeifer G. P. Hypermethylation of the CpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers. Cancer Res 2001; 61(7)3105–3109
   PubMed Web of Science ®Google Scholar
• Lo K. W., Kwong J., Hui A. B., Chan S. Y., To K. F., Chan A. S., et al. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. Cancer Res 2001; 61(10)3877–3881
   PubMed Web of Science ®Google Scholar
• Byun D. S., Lee M. G., Chae K. S., Ryu B. G., Chi S. G. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma. Cancer Res 2001; 61(19)7034–7038
   PubMed Web of Science ®Google Scholar
• Wong M. L., Tao Q., Fu L., Wong K. Y., Qiu G. H., Law F. B., et al. Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma. Int J Oncol 2006; 28(3)767–773
   PubMed Web of Science ®Google Scholar
• Kuroki T., Trapasso F., Yendamuri S., Matsuyama A., Alder H., Mori M., et al. Promoter hypermethylation of RASSF1A in esophageal squamous cell carcinoma. Clin Cancer Res 2003; 9(4)1441–1445
   PubMed Web of Science ®Google Scholar
• Siewert J. R., Stein H. J. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 1998; 85(11)1457–1459
   PubMed Web of Science ®Google Scholar
• Herman J. G., Graff J. R., Myohanen S., Nelkin B. D., Baylin S. B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996; 93(18)9821–9826
   PubMed Web of Science ®Google Scholar
• Bouras T., Southey M. C., Venter D. J. Overexpression of the steroid receptor coactivator AIB1 in breast cancer correlates with the absence of estrogen and progesterone receptors and positivity for p53 and HER2/neu. Cancer Res 2001; 61(3)903–907
   PubMed Web of Science ®Google Scholar
• Li J. Y., Ershow A. G., Chen Z. J., Wacholder S., Li G. Y., Guo W., et al. A case-control study of cancer of the esophageal and gastric cardia in Linxian. Int J Cancer 1989; 43(5)755–761
   PubMed Web of Science ®Google Scholar
• Roth M. J., Hu N., Emmert-Buck M. R., Wang Q. H., Dawsey S. M., Li G., et al. Genetic progression and heterogeneity associated with the development of esophageal squamous cell carcinoma. Cancer Res 2001; 61(10)4098–4104
   PubMed Web of Science ®Google Scholar
• Lerman M. I., Minna J. D. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. Cancer Res 2000; 60(21)6116–6133
   PubMed Web of Science ®Google Scholar
• Klump B., Hsieh C. J., Holzmann K., Gregor M., Porschen R. Hypermethylation of the CDKN2/p16 promoter during neoplastic progression in Barrett's esophagus. Gastroenterology 1998; 115(6)1381–1386
   PubMed Web of Science ®Google Scholar
• Yamaguchi S., Kato H., Miyazaki T., Sohda M., Kimura H., Ide M., et al. RASSF1A gene promoter methylation in esophageal cancer specimens. Dis Esophagus 2005; 18(4)253–256
   PubMed Web of Science ®Google Scholar
• Foster S. A., Wong D. J., Barrett M. T., Galloway D. A. Inactivation of p16 in human mammary epithelial cells by CpG island methylation. Mol Cell Biol 1998; 18(4)1793–1801
   PubMed Web of Science ®Google Scholar
• Shim Y. H., Kang G. H., Ro J. Y. Correlation of p16 hypermethylation with p16 protein loss in sporadic gastric carcinomas. Lab Invest 2000; 80(5)689–695
   PubMed Web of Science ®Google Scholar
• Bird A. Molecular biology. Methylation talk between histones and DNA. Science 2001; 294(5549)2113–2115
   Google Scholar
• Shivakumar L., Minna J., Sakamaki T., Pestell R., White M. A. The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol Cell Biol 2002; 22(12)4309–4318
   PubMed Web of Science ®Google Scholar